![](https://webarchive.library.unt.edu/eot2008/20090514035106im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090514035106im_/http://www.cancer.gov/images/spacer.gif)
| A substance being studied in the treatment of chronic myelogenous leukemia. PHA-739358 may stop tumor growth by blocking certain enzymes needed for cancer cells to divide and causing them to die. It is a type of kinase inhibitor. |
Previous Definitions: | Peutz-Jeghers syndrome, PF-00299804, PF-3512676, PG, PGE1 | Next Definitions: | phagocyte, phagocytosis, phantom limb pain, pharmacogenetics, pharmacogenomics |
|
![](https://webarchive.library.unt.edu/eot2008/20090514035106im_/http://www.cancer.gov/images/spacer.gif) |